The DOI matches its Crossref record.
Interleukin 1 induces interleukin 1. II. Recombinant human interleukin 1 induces interleukin 1 production by adult human vascular endothelial cells.
Abstract
Interleukin 1 (IL-1) alters several potentially pathogenic endothelial cell (EC) functions. The authors report here that recombinant human IL-1 (rIL-1) alpha (0.1 to 10 ng/ml) or IL-1-beta (1 to 100 ng/ml) induce concentration- and time-dependent increases in IL-1-beta mRNA levels in EC derived from adult human saphenous vein. rIL-1 induced IL-1-alpha mRNA only in EC treated concomitantly with cycloheximide (2 micrograms/ml). IL-1-beta mRNA production began within 1 hr of exposure to rIL-1, peaked after 24 hr, and declined thereafter. Actinomycin D prevented the appearance of IL-1 mRNA in rIL-1-treated EC. rIL-1 also induced the release of biologically active IL-1 from EC, which was inhibited by cycloheximide (1 microgram/ml). When compared on the basis of their activity in the thymocyte costimulation assay, rIL-1-alpha and rIL-1-beta were equipotent as inducers of IL-1 production by EC. EC stimulated with rIL-1 produced prostaglandin E2, which inhibits IL-1 production by other cell types and also decreases the responsiveness of thymocytes to IL-1. When EC were exposed to rIL-1 in the presence of indomethacin (1 microgram/ml), which blocked prostaglandin E2 production, greater amounts of rIL-1-induced IL-1 release were detected, although the inhibitor did not affect IL-1-beta mRNA levels. IL-1-induced IL-1 production was unlikely to be caused by endotoxin contamination of tissue culture media or IL-1 preparations, because the lipopolysaccharide (LPS) antagonist polymyxin B (10 micrograms/ml) blocked LPS-induced IL-1 production by EC but did not affect IL-1 release in response to rIL-1-beta (100 ng/ml). The IL-1-inducing property of rIL-1-beta was heat-labile, whereas heated LPS stimulated EC IL-1 production. The source of IL-1 in our cultures was not monocyte/macrophages, as treatment of EC with monoclonal antibody to the monocyte antigen Mo2 under conditions that lysed adherent peripheral blood monocytes did not affect production of IL-1 by EC in response to LPS (1 microgram/ml) or rIL-1-beta (100 ng/ml). IL-1 elicits a coordinated program of altered endothelial function that increases adhesiveness for leukocytes and coagulability. IL-1-induced IL-1 gene expression in human adult EC could thus provide a positive feedback mechanism in the pathogenesis of vascular disease including atherosclerosis, vasculitis, and allograft rejection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Interleukin-1 and interleukin-1 antagonism
Dinarello, C. (1991) · Blood · doi:10.1182/blood.v77.8.1627.1627 · Cited by 2,304
Cytokines in Atherosclerosis: Pathogenic and Regulatory Pathways
Tedgui, A., & Mallat, Z. (2006) · Physiological Reviews · doi:10.1152/physrev.00024.2005 · Cited by 1,701
Bone, R. C. (1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-115-6-457 · Cited by 1,368
The Tumor Necrosis Factor Ligand and Receptor Families
Bazzoni, F., & Beutler, B. (1996) · New England Journal of Medicine · doi:10.1056/nejm199606273342607 · Cited by 1,225
COVID-19 is, in the end, an endothelial disease
Libby, P., & Lüscher, T. (2020) · European Heart Journal · doi:10.1093/eurheartj/ehaa623 · Cited by 961
Self-citationNLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis
Grebe, A., Hoss, F., & Latz, E. (2018) · Circulation Research · doi:10.1161/circresaha.118.311362 · Cited by 926
Immune Mechanisms in Atherosclerosis
Hansson, G. K. (2001) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/hq1201.100220 · Cited by 876
Interleukin-1 Beta as a Target for Atherosclerosis Therapy
Libby, P. (2017) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.09.028 · Cited by 619
Self-citationSchleef, R. R., Bevilacqua, M. P., Sawdey, M., Gimbrone, M. A., & Loskutoff, D. J. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)60636-2 · Cited by 546
Libby, P., Warner, S. J., & Friedman, G. B. (1988) · Journal of Clinical Investigation · doi:10.1172/jci113346 · Cited by 533
Self-citationDe Caterina, R., Cybulsky, M. I., Clinton, S. K., Gimbrone, M. A., & Libby, P. (1994) · Arteriosclerosis and Thrombosis: A Journal of Vascular Biology · doi:10.1161/01.atv.14.11.1829 · Cited by 470
Self-citationNuclear factor kappa-B and the heart
Valen, G., Yan, Z.-Q., & Hansson, G. K. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01377-8 · Cited by 447
Loppnow, H., & Libby, P. (1990) · Journal of Clinical Investigation · doi:10.1172/jci114498 · Cited by 375
Self-citationNew Concepts on the Pathogenesis of Fever
Dinarello, C. A., Cannon, J. G., & Wolff, S. M. (1988) · Clinical Infectious Diseases · doi:10.1093/clinids/10.1.168 · Cited by 367
Shreeniwas, R., Koga, S., Karakurum, M., Pinsky, D., Kaiser, E., Brett, J., Wolitzky, B. A., Norton, C., Plocinski, J., & Benjamin, W. (1992) · Journal of Clinical Investigation · doi:10.1172/jci116122 · Cited by 334
Functions of interleukin 1 receptor antagonist in gene knockout and overproducing mice.
Hirsch, E., Irikura, V. M., Paul, S. M., & Hirsh, D. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.20.11008 · Cited by 316
Interleukin-1β in Coronary Arteries of Patients With Ischemic Heart Disease
Galea, J., Armstrong, J., Gadsdon, P., Holden, H., Francis, S. E., & Holt, C. M. (1996) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/01.atv.16.8.1000 · Cited by 310
In situ production of TNF-α, IL-1β and IL-2R in ANCA-positive glomerulonephritis
Noronha, I. L., Krüger, C., Andrassy, K., Ritz, E., & Waldherr, R. (1993) · Kidney International · doi:10.1038/ki.1993.98 · Cited by 282
Tilders, F. J. H., DeRuk, R. H., Van Dam, A.-M., Vincent, V. A. M., Schotanus, K., & Persoons, J. H. A. (1994) · Psychoneuroendocrinology · doi:10.1016/0306-4530(94)90010-8 · Cited by 277
Cytokine production in muscle tissue of patients with idiopathic inflammatory myopathies
Lundberg, I., Ulfgren, A., Nyberg, P., Andersson, U., & Klareskog, L. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400514 · Cited by 271
Fuster, J. J., & Walsh, K. (2018) · Circulation Research · doi:10.1161/circresaha.117.312115 · Cited by 162
Endothelial Cell Activation by Pore-Forming Structures: Pivotal Role for Interleukin-1α
Saadi, S., Holzknecht, R. A., Patte, C. P., & Platt, J. L. (2000) · Circulation · doi:10.1161/01.cir.101.15.1867 · Cited by 87
Bonfield, T. L., Colton, E., & Anderson, J. M. (1989) · Journal of Biomedical Materials Research · doi:10.1002/jbm.820230602 · Cited by 76
Kasturi, B. S., & Stein, D. G. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2008.0751 · Cited by 57
“…sites by means of VT (Bach-y-Rita, 2003), either through the ventricles or by movement through extracellular fluid and spaces, thereby activating further cytokine (IL-1) production down-stream from the initial injury (Warner et al., 1987) and activating a rolling cascade of inflammatory reaction.”
Differential regulation of endothelial cell activation by complement and interleukin 1α
Brunn, G. J., Saadi, S., & Platt, J. L. (2006) · Circulation Research · doi:10.1161/01.res.0000216071.87981.16 · Cited by 47
Metadata
- Authors
- Warner, S. J. C., Auger, K. R., & Libby, P.
- Venue
- The Journal of Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 1987-09
- Volume
- 139
- Issue
- 6
- Pages
- 1911-1917
- ISSN
- 0022-1767 (ISSN-L)
- 1550-6606
- OpenAlex
- W1564545106
- Cited by
- 279
- References
- 0
- FWCI
- 9.46
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.